vTv Therapeutics
is a North Carolina-based biotechnology company that develops small molecule drug candidates for the treatment of diabetes, cancer and renal diseases... Read morevTv Therapeutics
is a North Carolina-based biotechnology company that develops small molecule drug candidates for the treatment of diabetes, cancer and renal diseases... Read more
News
Mar 21, 2025
Seeking Alpha
vTv Therapeutics: vTv Therapeutics GAAP EPS of -$0.55, revenue of $0.02M
Mar 21, 2025
Life Care News
vTv Therapeutics: vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Mar 20, 2025
Owler
vTv Therapeutics, Inc.: vTv Therapeutics's revenue changed from $1M in Sep 2024 to $1.02M in Dec 2024
Mar 20, 2025
Yahoo
vTv Therapeutics: VTv Therapeutics: Q4 Earnings Snapshot
Mar 20, 2025
Yahoo
vTv Therapeutics: vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Mar 18, 2025
Clinical Trials Arena
vTv Therapeutics: FDA removes hold on vTv's cadisegliatin clinical programme for diabetes
Dec 02, 2024
Benzinga
vTv Therapeutics: vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
Nov 13, 2024
Owler
vTv Therapeutics, Inc.: vTv Therapeutics's revenue had no change from Jun 2024 to Sep 2024
Nov 12, 2024
Marketscreener
vTv Therapeutics: VTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update
Jul 31, 2024
The Business Journals: Greensboro/Winston-Salem/High Point
vTv Therapeutics: vTv Therapeutics' stock plunges after FDA pauses High Point company's diabetes drug development
vTv Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10